Decreases the percentage of KCs and the activation of M1 macrophages in liver with inhibited TLR4/NF-κB signaling pathway. Alleviates liver inflammation in NAFLD mice. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.